Why recurrent sprains are not the same injury twice

Rolling the same ankle a second time — or a third — rarely feels like coincidence. Clinically, it is not. A recurring sprain is a different problem from the original injury, and understanding why matters for knowing when to act.

Roughly 90% of ankle sprains involve an inversion twist that stresses the anterior talofibular ligament (ATFL) and the calcaneofibular ligament (CFL) — the two lateral restraints that keep the joint from buckling under load. When these ligaments heal fully, normal mechanics are restored. The difficulty is that they do not always heal fully. Soft tissue that knits together with residual laxity may feel functional during daily walking yet fail at the moment of sudden lateral demand: a change of direction, an uneven pavement, a step off a kerb.

Recurrence, in this light, is a signal rather than bad luck. It indicates that the ATFL and CFL have not regained sufficient tensile strength to maintain joint congruence under real-world stress — a state known as chronic ankle instability. Each time the ankle gives way, the talar dome — the rounded top surface of the heel bone that articulates with the lower leg — absorbs forces it was not designed to handle in that position: abnormal shear and compressive loading transmitted through a momentarily unsupported joint.

This matters because the talar cartilage accumulates the consequences silently. An episode of giving way is not a return to baseline; it may be a progression event for cartilage damage that was already beginning after the first sprain. The cumulative nature of that damage is what distinguishes recurrent sprains from a single injury that heals cleanly.

The diagnostic gap — why cartilage damage hides after ankle sprains

An X-ray after an ankle sprain is designed to answer one question: is there a fracture? When the answer is no, most patients are reassured and sent home. The image, however, says nothing about the cartilage — and that silence is clinically significant.

An estimated 50–70% of significant ankle sprains carry osteochondral lesions of the talus (OLTs) at the time of injury, yet plain radiographs routinely miss them. X-ray visualises cortical bone; it cannot resolve the thin cartilage surface of the talar dome or the early subchondral changes that precede visible bone damage. Think of it as seeing the scaffold but not the lining — structurally intact on film does not mean undamaged in practice.

MRI is the tool that closes this gap, but referral for MRI rarely happens at the acute stage. In most pathways, re-imaging is only requested once symptoms have persisted for several months — by which time a small lesion may already have enlarged under the repeated mechanical stress of ongoing activity or further giving way.

Compounding the delay, the early symptoms of OLT — a deep aching sensation, intermittent swelling, morning stiffness — overlap closely with what most people expect after any significant sprain. Self-triage is unreliable here: there is no symptom pattern that reliably distinguishes uncomplicated soft-tissue bruising from covert cartilage damage without imaging.

How long should you wait — the conservative window explained

Rest, physiotherapy, and bracing are the right starting point — not a failure to act decisively. Conservative care for acute, non-displaced osteochondral lesions of the talus achieves clinically successful results in roughly 50% of cases, which means that for many patients it is both appropriate and sufficient. The standard approach — activity modification, bracing, anti-inflammatory medication, physiotherapy, and protected weight-bearing in a boot where needed — addresses pain and swelling while giving soft tissue a genuine chance to recover.

The question is not whether to try conservative care, but how long to continue before the balance shifts. The American Academy of Orthopaedic Surgeons frames the outer boundary clearly: if swelling or pain persists for several weeks despite conservative measures, or if weight-bearing remains difficult, specialist review is warranted. In clinical practice, a 6–12 week physiotherapy trial is commonly used as a working outer limit for ankle cartilage presentations before escalating to assessment and imaging.

Recurrent sprains change the calculus. Current evidence does not set a precise week-count for people with recurring episodes specifically, and extending the conservative window indefinitely on the assumption that "more physiotherapy will eventually work" carries a risk that is not present in a straightforward first injury.

That risk centres on lesion size. Each episode of giving way exposes the talar dome to the abnormal loading described earlier — and a lesion that begins small enough to respond to conservative care alone may, over successive recurrences, expand past the size thresholds at which cartilage-sparing treatment remains effective. Waiting several months through a third or fourth recurrence is a different clinical decision from waiting the same period after a single acute sprain.

In practical terms, two or more significant recurrences within a twelve-month period — particularly where swelling persists between episodes, or where activity levels have had to be curtailed — represents a reasonable trigger for specialist assessment rather than a further extension of watchful waiting.

The lesion size threshold that changes what treatment can achieve

Two numbers define the boundary between straightforward and complex when it comes to talar cartilage damage. Lesions with a mean diameter below 15 mm — or below approximately 150 mm² on MRI — respond well to bone marrow stimulation and cartilage-targeted procedures; published series report no treatment failures in this range after arthroscopic debridement and microfracture. Shift above those thresholds and the picture changes sharply: in one study, only 3% of lesions at or above 15 mm diameter achieved a successful outcome with the same technique.

What makes this clinically pressing is that a small OLT is not a fixed finding. Cartilage damage can progress — silently, between episodes of giving way, without any clear change in day-to-day symptoms — and the longer an unstable ankle goes without imaging, the higher the probability that a lesion once in the 'treatable' range has expanded into the 'more complex' one. The lesion caught after a first or second recurrence is, statistically, a different clinical problem from the same lesion found two or three episodes later.

The downstream risk matters too. Post-traumatic ankle osteoarthritis predominantly affects younger adults — the same active 20–40-year-old demographic that sustains most significant ankle sprains. Unlike hip or knee OA, where age is a central driver, ankle OA is overwhelmingly injury-driven, which means it is, at least in part, a preventable outcome given timely diagnosis.

The message is not alarmist. A small OLT identified early carries genuinely good prospects. The point is that the earlier the assessment, the more treatment options remain on the table.

What a specialist assessment adds — and what to expect

The most common reason patients delay referral is not scepticism about their symptoms — it is the fear of being told they need surgery. For many, that concern is misplaced. A specialist assessment often confirms that conservative care or a targeted injection-based approach is still appropriate; the assessment clarifies the picture rather than committing anyone to a particular treatment pathway.

What the assessment adds, above all, is imaging information that conservative management cannot generate. MRI identifies whether an osteochondral lesion is present, measures its size precisely, and grades subchondral involvement. The size thresholds described in the previous section — 15 mm mean diameter and 150 mm² on MRI — determine which treatments are likely to succeed. Without those measurements, the clinical default is continued waiting; with them, a specific, staged plan becomes possible.

A first consultation typically covers a structured clinical history — number of episodes, symptom pattern between sprains, whether instability is predictable or unpredictable — and mechanical testing for ligamentous laxity. MRI will be requested if not already performed; if an earlier scan exists, a specialist can interpret it in the context of the current presentation rather than in isolation.

The practical trigger for seeking that assessment is the persistent or recurring picture outlined in the previous section. When those symptoms have not clearly resolved, having the lesion picture on MRI changes the decision from open-ended watchful waiting to a specific plan — whether a defined continuation of rehabilitation, an image-guided regenerative injection, or a more targeted intervention if lesion size warrants it.

Treatment options when conservative care is not enough

For lesions that persist beyond a structured physiotherapy trial, the pathway moves to image-guided biologic support before any consideration of surgery.

Biologic and injection stage

At this stage the goal shifts from symptom management to active tissue support. Injectable collagen scaffold approaches — such as the ChondroFiller injection, delivered as an ultrasound-guided outpatient procedure — are designed to recruit the patient's own progenitor cells to build new cartilage matrix within the defect. This option sits at the biologic/injection stage of the pathway and is most appropriate for smaller, contained lesions where the cartilage architecture has not been extensively disrupted. Platelet-rich plasma is sometimes used alongside scaffold approaches to support healing, though the evidence for biological adjuncts in this specific context remains under evaluation rather than an established protocol.

Surgical options

When lesion size or severity exceeds what injection-stage management can address, surgical options become relevant. Bone marrow stimulation — including microfracture — produces reliable results for lesions below the 15 mm diameter and 150 mm² MRI thresholds noted earlier; published series report near-complete failure rates once those boundaries are crossed. Larger or displaced lesions may require osteochondral grafting or autologous chondrocyte-based repair to restore a meaningful area of articular surface. Where post-traumatic ankle osteoarthritis has already progressed substantially, the eventual pathway may include ankle fusion or total ankle replacement — interventions that are more complex and irreversible than anything available at earlier stages.

The practical implication runs through the entire decision ladder: the smaller the lesion at assessment, the broader the range of cartilage-sparing choices that remain open, and the less likely any of those choices involves theatre.

1. [1] Sprained Ankle — Wikipedia. https://en.wikipedia.org/?curid=5701744 https://en.wikipedia.org/?curid=5701744